Robert F. Apple - 08 Jun 2021 Form 4 Insider Report for ANTARES PHARMA, INC.

Role
President & CEO, Director
Signature
/s/Lisa M. Kallebo as attorney-in-fact for Robert F. Apple
Issuer symbol
N/A
Transactions as of
08 Jun 2021
Net transactions value
-$194,139
Form type
4
Filing time
10 Jun 2021, 17:37:57 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRS Common Stock Tax liability $194,139 -44,223 -1.9% $4.39 2,246,970 08 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.